By KIM BELLARD In 2025, we’ve got DNA all figured out, right? It’s been over fifty years since Crick and Watson (and Franklin) discovered the double helix structure. We know that permutations of just four chemical bases (A, C, T, and G) allow the vast genetic complexity and diversity in the world. We’ve done the…
Every day, the Ohio River sends billions of gallons of water flowing past Louisville’s pumping station, where the Kentucky city’s utility sucks it up to turn it into tap water. To ensure it tastes good and is safe to drink, a small team of scientists and technicians is constantly testing the water for pH, odors,…
A KFF survey of state Medicaid officials examines state Medicaid and CHIP eligibility, enrollment, and renewal policies in place as of January 2025 as states return to routine operations following the unwinding of the continuous enrollment provision. The survey finds that states have broadly adopted policy and system changes to automate and improve the accuracy…
By MICHAEL MILLENSON It was a small anecdote, buried in a lengthy profile in The New Yorker of Commerce Secretary Howard Lutnick, “Donald Trump’s Tariff Dealmaker-in-Chief.” But as a patient safety activist, the stark depiction of the effect of medical error felt like a sudden shock. Lutnick, the article related, knew tragedy early in life: “his mother died…
In 1996, Guinea-Bissau seemed like an ideal research post for budding pediatrician Lone Graff Stensballe. Her supervisor, a fellow Dane named Peter Aaby, had spent nearly two decades collecting data on 100,000 people living in the mud brick homes of the West African country’s capital. Aaby and his partner, Christine Stabell Benn, believed that the…
Eikon Therapeutics’ IPO haul will support a lead program that could expand the scope of cancer immunotherapy. Eikon’s stock market debut builds on growing IPO momentum, following upsized offerings from Aktis Oncology and Veradermics. The post Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials appeared first on MedCity News.
The Trump administration has declared that it will aggressively combat chronic disease in America. Yet in its feverish purge of federal health programs, it has proposed eliminating the National Center for Chronic Disease Prevention and Health Promotion and its annual funding of $1.4 billion. That’s one of many disconnects between what the administration says about…
What is the impact of changing one treatment attribute on patient preferences for that treatment? This is a key question of interest for many patient preference studies. In practice, this is most often done by estimating the causal effect of changing one attribute of a profile while averaging over the distribution of the remaining profile…
EKALAKA, Mont. — There was no doctor on-site when a patient arrived in early June at the emergency room in the small hospital at the intersection of two dirt roads in this town of 400 residents. There never is. Dahl Memorial’s three-bed emergency department — a two-hour drive from the closest hospital with more advanced…
SANDY, Utah — Justo en las afueras de Salt Lake City se encuentra un viejo hotel de ladrillo de dos pisos. Hoy tiene una nueva función: refugio para personas mayores sin hogar. El refugio para Personas Médicamente Vulnerables —conocido como MVP, por sus siglas en inglés— está destinado a personas de 62 años en adelante,…